Abstract
The global increase in the incidence of chronic non-communicable diseases has encouraged the pharmaceutical industry to invest in the research and development (R&D) of new drugs capable of preventing or treating these diseases. However, the development of a drug is a time-consuming and costly process. In addition, about 90% of investigational products in development fail during clinical t…
